On Tuesday, the situation deteriorated drastically when US health authorities announced they would “pause” the rollout of the Johnson & Johnson vaccine; the company said it would immediately hold off on deliveries to Europe pending a review by the European Medicines Agency. In the days since, the view has grown in Government that the delay in the Johnson & Johnson vaccine could be short-lived. Too much cautionThirdly, an abundance of caution is too much caution. Advice that will affect the vaccination programme should not be given without regard for its consequences. After all, slowing down the vaccine programme will cost lives, too.

Source: The Irish Times April 17, 2021 00:00 UTC